Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AIDS and tuberculosis: the immunopathogenic processes].

E Păunescu1

  • 1Institutul de pneumoftiziologie Marius Nasta, Bucureşti.

Pneumoftiziologia : Revista Societatii Romane De Pneumoftiziologie
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Changes in cellular transcription on terms of the type of proliferative stimulus in immune-reactive lymphocyte cultures].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2015
Same author

Synthesis and antimalarial activity of new amino analogues of amodiaquine.

Medicinal chemistry (Shariqah (United Arab Emirates))·2008
Same author

[The electrophoretic study of serum proteins in pneumophthisiology].

Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie·1999
Same authorSame journal

[Rapid diagnosis in sero-hemorrhagic pleurisy].

Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie·1999
Same author

Reprimun--an antibiotic with large spectrum and immunomodulatory properties.

Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie·1994
Same author

Why the treatment with Reprimun could be efficient for tuberculosis prevention in HIV infected individuals.

Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie·1992

Human immunodeficiency virus (HIV) infection depletes CD4+ lymphocytes, weakening immune responses and enabling opportunistic infections like tuberculosis. Chemoprophylaxis for HIV patients should target autoimmune processes and HIV-facilitating factors to prevent immune deficiency.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) infection leads to CD4+ lymphocyte depletion, compromising immune capacity.
  • This immunodeficiency facilitates opportunistic infections and malignant processes, notably tuberculosis.
  • HIV-associated immunodeficiency allows latent tuberculosis to progress to active disease.

Purpose of the Study:

  • To elucidate the mechanisms of CD4+ lymphocyte depletion in HIV infection.
  • To explain how HIV-induced immunodeficiency promotes tuberculosis development.
  • To propose a comprehensive approach to tuberculosis chemoprophylaxis in HIV-infected individuals.

Main Methods:

  • Review of immunological mechanisms underlying CD4+ T-cell depletion.

Related Experiment Videos

  • Analysis of the interplay between HIV infection, immune surveillance, and tuberculosis pathogenesis.
  • Conceptual framework for targeted chemoprophylaxis strategies.

    • Main Results:

    • CD4+ T-cell depletion results from facilitating antibodies, cytokines, and autoimmune processes.
    • Impaired immune surveillance due to CD4+ T-cell loss permits reactivation of latent tuberculosis.
    • Autoimmune mechanisms and factors facilitating HIV infection contribute significantly to immune deficit.

    Conclusions:

    • Tuberculosis chemoprophylaxis in HIV-infected individuals requires addressing the root causes of immune deficit.
    • Targeting autoimmune processes and HIV-facilitating factors is crucial for effective prevention.
    • A multi-faceted approach is necessary to manage tuberculosis risk in the context of HIV infection.